Article Text

PDF
SP0107 Hot session: scleroderma treatment
  1. CP Denton
  1. Centre for Rheumatology, Royal Free Hospital and Ucl Medical School, London, United Kingdom

Abstract

This presentation will provide an up to date summary of current management of SSc that can be applied across the disease spectrum. Systemic sclerosis (SSc) remains a challenging multifaceted rheumatic disease with high mortality and morbidity. However, treatments are emerging for some aspects of the disease and long term survival has improved significantly over the past decades. This session will review the clinical challenge and current therapeutic landscape of SSc focusing on practical aspects of management such as identifying and treating significant organ based complications in the lung, heart, kidney and gastrointestinal tract. Current approaches to overall disease management will be summarized including the use of haemopoietic stem cell transplant in selected poor prognosis cases. Recently updated EULAR/EUSTAR treatment recommendations will be reviewed and other evidence based management guidelines will be considered within a practical patient-focused framework.

Disclosure of Interest C. Denton Grant/research support from: Inventiva, CSL Behring, GSK, Bayer, Consultant for: GSK, Actelion, Inventiva, Roche

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.